BRWD1

(redirected from N143)

BRWD1

A gene on chromosome 21q22.2 that encodes a member of the WD-repeat protein family, which are involved in various cellular processes, including cell cycle progression, signal transduction, apoptosis and gene regulation. BRWD1 is located within the Down syndrome region-2 on chromosome 21; it may be a transcriptional activator, and may be involved in chromatin remodelling.
References in periodicals archive ?
A communique issued by the Federation Account Allocation Committee (FAAC) confirmed that from the total revenue of N769.523 billion, the Federal Government received N299.799 billion, the states received N190.381 billion, and the local government councils received N143.569 billion.
Last month, our electricity bills rose to N143,000 [$720] a month from N80,000 [$400]," Falayi adds.
The bottles affected by Wednesday's decision carry the labels: N229, N119, N143, N180, N181, N190, N216, N218 and N219.
The Supreme Council of Health (SCH) has issued a circular to all pharmacies in Qatar to withdraw batch number (N066) and (N143) of Panadol 100ml syrup for children and babies.
Clusters Sites Cluster specific amino acid changes KOL 507 (2007, 2009) 13 D26, N53, C59, L85, V95, N143 (99%), T145, N171, T209, F214, T216, T217, T226 KOL 596 (2007, 2009) 7 P3, R59, A60, S103, 1106, A171, 1226 KOL 989 (2007-2009) 19 V23, R41, A56, H59, K67, V82, T84, 195, L98, N101, E112, M129 (80%), I144, V145, I171, K196, R224, A226, K229 NIV 6196 (2009-2013) 28 M6, F22, N25 (99%), G26 , L59, W67, S74, T76 , R78, I81, T86, S91, R108 (99%), 1111 (90%), I112, L119, V123 (85%), V129, N139, Y171, I198, N205 (77%), C206, D207, S213, P215, E217, * 220 Some cluster specific changes were seen in variable percentage of sequences in cluster and those absent from all other clusters are highlighted with italic font.
In all the stations that have the products, consumers were seen buying at the official price of between N143 and N145.
In Nigeria, growth is also positive, with pharmaceuticals expenditure projected to grow from N143.65bn ($921m) in 2011 to N167.28bn ($105bn) in 2012, according to Business Monitor International's (BMI) report on the country's healthcare and pharmaceuticals industry for the third quarter of 2012.
It explained that N115 billion worth of shares was initially offered to be bought but only N88.08 billion was allotted, though subscribers made bids worth N143.48 billion.
He talked about a 'staggering N143 billion debt'and public sector workers not earning salaries for years.